These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30935555)
1. Efficacy of individualized homeopathic treatment of insomnia: Double-blind, randomized, placebo-controlled clinical trial. Michael J; Singh S; Sadhukhan S; Nath A; Kundu N; Magotra N; Dutta S; Parewa M; Koley M; Saha S Complement Ther Med; 2019 Apr; 43():53-59. PubMed ID: 30935555 [TBL] [Abstract][Full Text] [Related]
2. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial. Tek C; Palmese LB; Krystal AD; Srihari VH; DeGeorge PC; Reutenauer EL; Guloksuz S Schizophr Res; 2014 Dec; 160(1-3):180-5. PubMed ID: 25454802 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials. Huang Z; Zhan S; Chen C; Zhang R; Zhou Y; He J; Lin Z; Bao C; Zhu S; Zhao J; Zhang S; Jiang Y; Wang Y Sleep; 2024 Feb; 47(2):. PubMed ID: 37875349 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of suanzaoren decoction for chronic insomnia disorder in adults: study protocol for randomised, double-blind, double-dummy, placebo-controlled trial. Zhou QH; Wang HL; Zhou XL; Xu MB; Zhang HF; Huang LB; Zheng GQ; Lin Y BMJ Open; 2017 Apr; 7(4):e014280. PubMed ID: 28377394 [TBL] [Abstract][Full Text] [Related]
5. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869 [TBL] [Abstract][Full Text] [Related]
6. The effect of a homeopathic complex on psychophysiological onset insomnia in males: a randomized pilot study. Harrison CC; Solomon EM; Pellow J Altern Ther Health Med; 2013; 19(5):38-43. PubMed ID: 23981403 [TBL] [Abstract][Full Text] [Related]
7. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597 [TBL] [Abstract][Full Text] [Related]
9. Effects of suvorexant on the Insomnia Severity Index in patients with insomnia: analysis of pooled phase 3 data. Herring WJ; Connor KM; Snyder E; Snavely DB; Morin CM; Lines C; Michelson D Sleep Med; 2019 Apr; 56():219-223. PubMed ID: 30522875 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Violet oil, a traditional Iranian formula, in patients with chronic insomnia: A randomized, double-blind, placebo-controlled study. Feyzabadi Z; Rezaeitalab F; Badiee S; Taghipour A; Moharari F; Soltanifar A; Ahmadpour MR J Ethnopharmacol; 2018 Mar; 214():22-28. PubMed ID: 29217495 [TBL] [Abstract][Full Text] [Related]
12. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study. Murphy P; Moline M; Mayleben D; Rosenberg R; Zammit G; Pinner K; Dhadda S; Hong Q; Giorgi L; Satlin A J Clin Sleep Med; 2017 Nov; 13(11):1289-1299. PubMed ID: 29065953 [TBL] [Abstract][Full Text] [Related]
13. Response to placebo acupuncture in insomnia: a secondary analysis of three randomized controlled trials. Yeung WF; Chung KF; Yu BY; Lao L Sleep Med; 2015 Nov; 16(11):1372-1376. PubMed ID: 26498238 [TBL] [Abstract][Full Text] [Related]
14. Aloysia citriodora Palau (lemon verbena) for insomnia patients: A randomized, double-blind, placebo-controlled clinical trial of efficacy and safety. Afrasiabian F; Mirabzadeh Ardakani M; Rahmani K; Azadi NA; Alemohammad ZB; Bidaki R; Karimi M; Emtiazy M; Hashempur MH Phytother Res; 2019 Feb; 33(2):350-359. PubMed ID: 30450627 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243 [TBL] [Abstract][Full Text] [Related]
16. Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial. Jakobsen G; Engstrøm M; Paulsen Ø; Sjue K; Raj SX; Thronæs M; Hjermstad MJ; Kaasa S; Fayers P; Klepstad P Trials; 2018 Dec; 19(1):707. PubMed ID: 30591073 [TBL] [Abstract][Full Text] [Related]
17. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. Zick SM; Wright BD; Sen A; Arnedt JT BMC Complement Altern Med; 2011 Sep; 11():78. PubMed ID: 21939549 [TBL] [Abstract][Full Text] [Related]
18. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Walsh JK; Krystal AD; Amato DA; Rubens R; Caron J; Wessel TC; Schaefer K; Roach J; Wallenstein G; Roth T Sleep; 2007 Aug; 30(8):959-68. PubMed ID: 17702264 [TBL] [Abstract][Full Text] [Related]
19. Exploring the Effect of Lactium™ and Zizyphus Complex on Sleep Quality: A Double-Blind, Randomized Placebo-Controlled Trial. Scholey A; Benson S; Gibbs A; Perry N; Sarris J; Murray G Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218661 [TBL] [Abstract][Full Text] [Related]